Table 2. Prevalence of metabolic syndrome and risk factors defined by ATP III1 and IDF2.
| Characteristics | Criterion 1. ATP III, n (%) | Criterion 2. IDF, n (%) | |||||
|---|---|---|---|---|---|---|---|
| Baseline (n=1,282) | Follow-up (n=494) | P | Baseline (n=1,282) | Follow-up (n=494) | P | ||
| Metabolic syndrome (MS) | 0.025‡ | 0.001‡ | |||||
| No | 1,160 (90.5) | 429 (86.8) | 1,179 (92.0) | 453 (91.7) | |||
| Yes | 122 (9.5) | 65 (13.2) | 103 (8.0) | 73 (14.8) | |||
| Abdominal obesity | 0.052‡ | 0.052‡ | |||||
| No | 1,153 (89.9) | 459 (92.9) | 1,153 (89.9) | 459 (92.9) | |||
| Yes | 129 (10.0) | 35 (7.1) | 129 (10.1) | 35 (7.1) | |||
| High blood pressure | 0.001‡ | 0.230‡ | |||||
| No | 1,077 (84.0) | 401 (81.2) | 1,106 (86.3) | 465 (94.1) | |||
| Yes | 150 (11.7) | 89 (18.0) | 121 (9.4) | 25 (5.1) | |||
| No data | 55 (4.3) | 4 (0.8) | 55 (4.3) | 4 (0.8) | |||
| Elevated triglycerides level | 0.000‡ | 0.000‡ | |||||
| No | 1,172 (91.4) | 353 (71.5) | 1,262 (98.4) | 424 (85.8) | |||
| Yes | 110 (8.6) | 141 (28.5) | 20 (1.6) | 70 (14.2) | |||
| Low HDL-cholesterol level | 0.000‡ | 0.000‡ | |||||
| No | 1,137 (88.7) | 359 (72.7) | 1,137 (88.7) | 359 (72.7) | |||
| Yes | 145 (11.3) | 109 (22.1) | 145 (11.3) | 109 (22.1) | |||
| No data | – | 26 (5.2) | – | 26 (5.2) | |||
| Elevated fasting glycemia level | – | – | |||||
| No | 1,282 (100) | 414 (83.8) | 1,282 (100) | 414 (83.8) | |||
| Yes | – | 50 (10.1) | – | 50 (10.1) | |||
| No data | – | 30 (6.1) | – | 30 (6.1) | |||
1Criterion 1. ATP III, Experts Panel of the National Cholesterol Education Program, USA. Abdominal obesity with waist perimeter > percentile 90. Blood pressure > percentile 90. Triglycerides >110 mg/dL or > percentile 95. HDL cholesterol <40 mg/dL in both sexes or < percentile 5. Basal glucose >110 mg/dL or 2 hours after overload >140 mg/dL (15); 2Criterion 2. International Diabetes Federation, IDF. Abdominal obesity with waist perimeter > percentile 90. Blood pressure >130/85 mmHg. Triglycerides >150 mg/dL or > percentile 95. HDL cholesterol <40 mg/dL in both sexes. Basal glucose >110 mg/dL or two hours after overload >140 mg/dL (3); ‡, P value determined by Chi2 test.